MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus

Inclusion Criteria: * Females and males with Type 2 diabetes mellitus * Body Mass Index between 18 to 40 kg/m2, inclusive, at Screening * Hypomagnesemia defined as serum magnesium ≤ 1.5 mg/dL at Screening * Females must be non-pregnant, non-lactating, and have a negative serum pregnancy test before enrollment. Exclusion Criteria: * History of clinically significant GI, renal, hepatic, neurologic, hematologic, endocrine other than Type 2 diabetes mellitus, oncologic, pulmonary, immunologic, psychiatric, or cardiovascular disease.